Cremezin hits in the market in 5 moths from its launching.

Published: 2005-08-01 06:55:00

Updated: 2005-08-01 06:55:00

CJ pharmaceutical division recently launched Cremezin, a drug for delaying a kidney dialysis, and achieved a tremendous success just within 5 months from its market entry in Feb. this year to an extent that about 80 major hospitals with over 300 beds including Severance and Korea Univ. hospital m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK